Quest Diagnostics Inc  

(Public, NYSE:DGX)   Watch this stock  
Find more results for DGX
+0.28 (0.41%)
Nov 25 - Close
NYSE real-time data - Disclaimer
Currency in USD
Range 68.08 - 68.96
52 week 60.07 - 89.00
Open 68.44
Vol / Avg. 652,593.00/1.24M
Mkt cap 9.82B
P/E 14.21
Div/yield 0.38/2.22
EPS 4.82
Shares 143.35M
Beta 0.69
Inst. own 96%
Jan 27, 2016
Q4 2015 Quest Diagnostics Inc Earnings Release (Estimated) - 9:30AM EST - Add to calendar
Dec 2, 2015
Quest Diagnostics Inc at Evercore ISI Medtools & Outsourcing Investor Forum Add to calendar
Oct 22, 2015
Q3 2015 Quest Diagnostics Inc Earnings Release
Oct 22, 2015
Q3 2015 Quest Diagnostics Inc Earnings Call - Webcast
Sep 17, 2015
Quest Diagnostics Inc at Morgan Stanley Healthcare Conference
Sep 10, 2015
Quest Diagnostics Inc at Wells Fargo Healthcare Conference
More events from DailyFinance »    

Key stats and ratios

Q3 (Sep '15) 2014
Net profit margin 18.83% 7.90%
Operating margin 33.56% 13.22%
EBITD margin - 18.04%
Return on average assets 14.35% 6.24%
Return on average equity 30.64% 13.31%
Employees 45,000 -
CDP Score - 83 C


3 Giralda Farms
United States - Map
+1-973-5202700 (Phone)
+1-302-6555049 (Fax)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money


Quest Diagnostics Incorporated is a provider of diagnostic testing information services. The Company consists of two businesses: Diagnostic Information Services and Diagnostic Solutions. Diagnostic Information Services business, consists of two parts, develops and delivers diagnostic testing, information and services to patients, physicians, health plans, hospitals, accountable care organizations (ACOs), integrated delivery networks (IDNs), other commercial laboratories, patients and other customers. Diagnostics Information Services business also provides diagnostic information services, which includes providing clinical testing services, such as routine testing, gene-based and esoteric testing, anatomic pathology services and drugs-of-abuse testing. Diagnostic Solutions includes the Company’s other businesses, including central laboratory testing for pharmaceutical and medical device clinical trials, risk assessment services, diagnostic products and healthcare information technology.

Officers and directors

Stephen H. Rusckowski President, Chief Executive Officer, Director
Age: 57
Bio & Compensation  - Reuters
Mark J. Guinan Chief Financial Officer, Senior Vice President
Age: 53
Bio & Compensation  - Reuters
Michael E. Prevoznik Senior Vice President, General Counsel
Age: 53
Bio & Compensation  - Reuters
Trading Activity - Yahoo Finance
Jon Roger Cohen M.D. Senior Vice President, Chief Medical Officer
Age: 60
Bio & Compensation  - Reuters
Everett V. Cunningham Senior Vice President - Commercial
Age: 48
Bio & Compensation  - Reuters
James E. Davis Senior Vice President - Operations
Age: 52
Bio & Compensation  - Reuters
Catherine T. Doherty Senior Vice President - Clinical Franchises
Age: 52
Bio & Compensation  - Reuters
Daniel C. Stanzione Ph.D. Non-Executive Independent Chairman of the Board
Age: 69
Bio & Compensation  - Reuters
John C. Baldwin M.D. Independent Director
Age: 66
Bio & Compensation  - Reuters
Jenne K. Britell Ph.D. Independent Director
Age: 72
Bio & Compensation  - Reuters